Abstract
Corneal graft survival in 13 patients (14 eyes) receiving oral acyclovir following corneal transplantation for herpes simplex keratitis was compared to that in nine patients (9 eyes) who underwent penetrating keratoplasty for herpes simplex keratitis without receiving postoperative acyclovir. Mean age, duration of disease, and time of follow-up did not differ in the two groups. There were no recurrences of herpes simplex keratitis in any patient receiving acyclovir during a mean follow-up of 16.5 months compared to a 44% (4/9) recurrence rate in patients without acyclovir during a mean follow-up of 20.6 months (p < 0.01). Graft failure occurred in 14% (2/14) of acyclovir treatment eyes and in 56% (5/9) of the grafts in patients not receiving acyclovir. Long term prophylactic oral acyclovir significantly decreased the recurrence of herpes simplex keratitis and reduced corneal graft failure in patients with a history of recurrent herpes simplex keratitis who underwent corneal transplantation.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Abbreviations
- ACV:
-
acyclovir
- HSK:
-
herpes simplex keratitis
- PK:
-
penetrating keratoplasty
References
Langsten RHS, Pavan-Langston D, Dohlman CH. Penetrating keratoplasty for herpetic keratitis-prognostic and therapeutic determinants. Trans Am Acad Ophthalmol and Otol 1975; 79: 577.
Foster CS, Duncan J. Penetrating keratoplasty for herpes simplex keratitis. Am. J Ophthalmol 1981; 92: 336.
Rice NSC, Jones BR. Problems of corneal and herpetic keratitis. In: Ciba Foundation Symposium on Corneal Graft Failure. Amsterdam: Associated Scientific Publication, 1973: vol 15, 221–239.
Langsten RHS, Pavan-Langston D, Dohlman CH. Antiviral medications and corneal wound healing. Arch Ophthalmol 1974; 92: 509.
Cobo LM, Coster DJ, Rice MSC, Rice NSC, Jones BR. Prognosis and management of corneal transplants for herpetic keratitis. Arch Ophthalmol 1980; 98: 1755.
Spruance SL, Stewart JC, Rowe NH, McKeogh MB, Wenerstrom G, Freeman DJ. Treatment of recurrent herpes simplex labialis with oral acyclovir. J Infect Dis 1990; 161: 185.
Kaplowitz LG, Baker D, Gelb L. Prolonged continuous acyclovir treatment of normal adults with frequently recurring genital herpes simplex virus infection. JAMA 1991; 265: 747.
Beyer CF, Arens MQ, Hill GA, Rose BT, Beyer LR, Shanzlin D. Oral acyclovir reduces the incidence of recurrent herpes simplex keratitis in rabbits after penetrating keratoplasty. Arch Ophthalmol 1989; 107: 1200.
Clinical trials supported by the NEI: NIH publication No. 90-2910 October 1990, p 64.
Polack FM, Kaufman HE. Penetrating keratoplasty in herpes simplex keratitis. Am J Ophthalmol 1972; 73: 908.
Bridgen D, Rossling AE, Woods NC. Renal function after acyclovir intravenous injection. Am J Med (supplement) Acyclovir symposium; September 1981.
Shriver K. Re-inervation of the corneal graft. Acta Ophthalmol 1978; 56: 1013.
Kaye SB, Madan N, Dowd TC, Hart CA, McCarthy K, Patterson A. Ocular shedding of herpes simplex virus. Br J Ophthalmol 1990; 74: 114.
Kaufman HE, Brown DC, Ellison EM. Recurrent herpes in the rabbit and man. Science 1967; 156: 1628.
Quinn RP, Wolberg G, Medzihradsky J, Elion G. Effect of acyclovir on various murine in vivo and in vitro immunologic assay systems. Am J Med (supplement). Acyclovir symposium September 1981.
Picker, LA, Kirkness CM, Rice NS, Steele AD. The changing management and improved prognosis for corneal grafting in herpes simplex keratitis. Ophthalmology 1989; 96(11): 1587–96.
Author information
Authors and Affiliations
Additional information
Presented as a paper at The American Academy of Ophthalmology, annual meeting in Anaheim, California 13–17 October 1991.
Rights and permissions
About this article
Cite this article
Foster, C.S., Barney, N.P. Systemic acyclovir and penetrating keratoplasty for herpes simplex keratitis. Doc Ophthalmol 80, 363–369 (1992). https://doi.org/10.1007/BF00154385
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00154385